Two-Year Outcomes in HeartMate 3 versus HeartWare HVAD Patients Implanted as Destination Therapy. - Coyle, L.; Gallagher, C.; Kukla, L.; Paliga, R.; Siemeck, R.; Yost, G.; Dia, M.; Tatooles, A. (Journal of Heart & Lung Transplantation, 2020)